A decision model to compare health care costs of olanzapine and risperidone treatment of schizophrenia in Germany
ثبت نشده
چکیده
Study population The study population comprised a hypothetical cohort of patients currently suffering from an acute episode of schizophrenia, and who were being considered for first-line treatment with a second-generation atypical antipsychotic. The patients were assumed to have a long-term history of relapsing schizophrenia and to have no other concurrent psychotic diagnoses or other significant health issues. In addition, the patients were assumed to have not received any form of previous treatment with atypical antipsychotics.
منابع مشابه
A decision model to compare health care costs of olanzapine and risperidone treatment of schizophrenia in Germany
Study population The study population comprised a hypothetical cohort of patients currently suffering from an acute episode of schizophrenia, and who were being considered for first-line treatment with a second-generation atypical antipsychotic. The patients were assumed to have a long-term history of relapsing schizophrenia and to have no other concurrent psychotic diagnoses or other significa...
متن کاملCost-effectiveness model comparing olanzapine and other oral atypical antipsychotics in the treatment of schizophrenia in the United States
BACKGROUND Schizophrenia is often a persistent and costly illness that requires continued treatment with antipsychotics. Differences among antipsychotics on efficacy, safety, tolerability, adherence, and cost have cost-effectiveness implications for treating schizophrenia. This study compares the cost-effectiveness of oral olanzapine, oral risperidone (at generic cost, primary comparator), quet...
متن کاملA cost-effectiveness clinical decision analysis model for schizophrenia.
A model was developed to estimate the medical costs and effectiveness outcomes of three antipsychotic treatments (olanzapine, haloperidol, and risperidone) for patients with schizophrenia. A decision analytic Markov model was used to determine the cost-effectiveness of treatments and outcomes that patients treated for schizophrenia may experience over a 5-year period. Model parameter estimates ...
متن کاملCost-effectiveness analysis of olanzapine and risperidone in Norway.
BACKGROUND Antipsychotic medications are the mainstay for schizophrenia treatment, and olanzapine and risperidone are popular choices among atypical antipsychotics in Norway. Our aim was to develop a decision analytic model to evaluate the cost-effectiveness of antipsychotics in a Norwegian setting. METHODS The Positive and Negative Symptom Scale (PANSS) score was used to measure effectivenes...
متن کاملOlanzapine versus risperidone. A prospective comparison of clinical and economic outcomes in schizophrenia.
OBJECTIVE To compare the clinical and economic outcomes associated with olanzapine and risperidone treatment for schizophrenia. DESIGN AND SETTING An international, multicentre, double-blind, prospective study. To facilitate economic comparisons, our sample was restricted to patients enrolled in US sites. 150 patients with a Diagnostic and Statistical Manual of mental disorders, 4th edition (...
متن کامل